ZetaGen Therapeutics Company
ZetaGen Therapeutics commercializes a small molecule-based osteoinductive platform technology to develop.
Technology:
Cell therapy
Industry:
Private, Small & Large Molecules
Headquarters:
Syracuse, New York, United States
Founded Date:
2015-01-01
Employees Number:
1-10
Investors Number:
3
Total Funding:
14200360
Last Funding Date:
2023-02-06
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership